Cargando…
The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodies
The optimal interval before receiving SARS-COV-2 vaccination for patients who have received anti-CD 20 monoclonal antibodies remains unclear. We considered original studies up to 29 October 2022 and conducted searches in Embase,Medrxiv, PubMed, and SSRN. We excluded search results that did not match...
Autores principales: | Liu, Kexin, Li, Jinyu, Xu, Gaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673919/ https://www.ncbi.nlm.nih.gov/pubmed/36372876 http://dx.doi.org/10.1080/21505594.2022.2146380 |
Ejemplares similares
-
Evaluation of neonatal outcomes in COVID-19 positive mothers who received monoclonal antibodies
por: Chen, Katherine, et al.
Publicado: (2023) -
Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
por: Makkouk, Amani, et al.
Publicado: (2015) -
Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013) -
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022) -
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
por: Inaba, Tohru, et al.
Publicado: (2022)